Loading...

DermTech, Inc.

DMTK•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.09
$-0.01(-11.32%)

DermTech, Inc. (DMTK) Stock Overview

Explore DermTech, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.0/100

Key Financials

Market Cap3.3M
P/E Ratio-0.08
EPS (TTM)$-2.65
ROE-0.80%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.03

DMTK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DermTech, Inc. (DMTK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.08 and a market capitalization of 3.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;